Pharma.Aero signs Memorandum Of Understanding with IATA

Pharma.Aero and IATA have signed a memorandum of understanding to foster collaboration with stakeholders using the CEIV pharma industry standard.
Nathan De Valck, chairman of Pharma.Aero, said: “Formalising the partnership with IATA is an important milestone. It will allow us to upscale our initiatives and enroll the projects within a larger international platform in the life science airfreight industry.
"The MOU underlines our vision to foster collaboration with all air cargo stakeholders that support the CEIV pharma industry standard."
Glyn Hughes, IATA’s global head of cargo, said: “The IATA CEIV Pharma certification programme provides participants in the air cargo value chain with the tools and the means to ensure that they are operating to the highest standards for the handling and transport of life saving medicines.
"This MoU between Pharma.aero and IATA formalises an ongoing collaboration between the two organisations with the aim of better assisting the industry in improving the quality of services for pharmaceutical handling and transport in the air cargo industry worldwide.”
Frank Van Gelder, secretary general of Pharma.Aero added: "The MOU underlines the mutual benefits for both IATA and Pharma.Aero. The Pharma.Aero members focus on creating content and become a reference to the different pharmaceutical companies and operators within airfreight life science. We are convinced this MOU will boost our initiatives and projects in the pipeline."
The MoU was signed during IATA’s World Cargo Symposium in Dallas. Pharma.Aero also hosted its general meeting during the WCS, with a large group of its members present, representing pharmaceutical shippers, airport communities, airlines, forwarders and handling agents.
The status of the ongoing projects was presented and a number of new projects were launched.
Read more Pharma Logistics news

Share this story
Facebook
Twitter
LinkedIn